cover image - Clayton’s Basic Pharmacology for Nurses - Elsevier E-Book on VitalSource, 20th Edition
ISBN: 9780443263996
Copyright: 2026
Publication Date: 01-31-2025
Page Count: 880
Imprint: Elsevier
List Price: $84.99

Clayton’s Basic Pharmacology for Nurses - Elsevier E-Book on VitalSource, 20th Edition

by Michelle J. Willihnganz, MS, RN, CNE and Samuel L. Gurevitz, PharmD, CGP

Elsevier eBook on VitalSource

cover image - Clayton’s Basic Pharmacology for Nurses - Elsevier E-Book on VitalSource, 20th Edition
ISBN: 9780443263996
Copyright: 2026
Publication Date: 01-31-2025
Page Count: 880
Imprint: Elsevier
List Price: $84.99
Most review copies are eBooks – how fast!
A review copy request is most likely to be fulfilled as an eBook on VitalSource rather than a print product, unless no eBook is available. eBooks become available in as little as a few hours. Print products will take between 7 and 10 days to arrive. To request a print copy, please contact us through the Evolve Support Center for further assistance or contact your Elsevier Sales Rep.
An Access Code
Important note
You are viewing the faculty version.
Students requesting access will be reported.
Student access
Technical Support
Contact your Elsevier Sales Rep to learn more about adopting this product
Help your students learn safe, effective nursing care for patients receiving drug therapy! Clayton’s Basic Pharmacology for Nurses, Twentieth Edition helps students understand the principles of pharmacology and apply them to nursing practice. This text explains how to make informed decisions about drug therapy, educate patients, and administer medications. This edition adds enhanced coverage of the NCSBN Clinical Judgment Measurement Model to prepare students for the critical thinking questions on the Next Generation NCLEX® (NGN) exam. Concise and easy to use, this essential resource teaches practical nursing students, as well as associate degree students, the basics of medication administration and drug actions.
    • NEW! Three new chapters address key topics: Drugs Used to Treat Immune and Inflammatory Disorders; Drugs Used to Treat Headaches; and Drugs Used to Treat Attention Deficit Hyperactivity Disorder
    • NEW! Video and animation icons direct students to supplementary videos or animations on the companion Evolve website
    • EXPANDED! Additional coverage of the NCSBN Clinical Judgment Measurement Model enhances The Nursing Process and Pharmacology chapter
    • UPDATED! Accurate and current content ensures students are learning the most current drugs and treatment protocols
    • Medication Safety Alerts and Clinical Pitfall boxes, as well as Do-Not-Confuse and High Alert icons highlight the importance of safe drug handling and administration
    • Nursing process application provides students with an overview of general principles of nursing care for each disorder, as well as specific nursing considerations for the drug treatment
    • Medication Administration unit clearly and visually outlines assessment, techniques, procedures, and documentation for safe administration of percutaneous, enteral, and parenteral drugs
    • Drug tables clearly outline generic and brand names, availability, and dosage ranges for key medications for each disorder
    • Lifespan Considerations boxes for Children and for Older Adults draw attention to information that is especially important when giving a specific drug to patients of those age groups
    • Clinical Goldmine boxes focus on best practices in the clinical setting
    • Extensive resources on the Evolve companion website, including math review, patient teaching guides, chapter review questions, video clips of medication administration, and animations of drug actions, help reinforce students’ understanding of key concepts
  • UNIT I: Introduction to Pharmacology
    1. Basic Principles of Pharmacology
    2. Drug Actions Across the Life Span
    3. The Nursing Process and Pharmacology
    4. Patient Education to Promote Health

    UNIT II: Medication Administration
    5. Principles of Medication Administration and Medication Safety
    6. Percutaneous Administration
    7. Enteral Administration
    8. Parenteral Administration: Safe Preparation
    9. Parenteral Administration: Intradermal, Subcutaneous, and Intramuscular
    10. Parenteral Administration: Intravenous

    UNIT III: Drugs Affecting Neurologic Disorders
    11. Drugs Affecting the Central and Peripheral Nervous System
    12. Drugs Used to Treat Neurodegenerative Disorders
    13. Drugs Used to Treat Seizure Disorders
    14. Drugs Used to Treat Headaches
    15. Drugs Used to Treat Pain: Focus on Opioids

    UNIT IV: Drugs Affecting Psychiatric Disorders
    16. Drugs Used to Treat Attention Deficit Hyperactivity Disorder
    17. Drugs Used to Treat Substance Use Disorders
    18. Drugs Used to Treat Schizophrenia
    19. Drugs Used to Treat Depressive and Bipolar Disorders
    20. Drugs Used to Treat Anxiety Disorders
    21. Drugs Used to Treat Sleep Disorders

    UNIT V: Drugs Affecting Cardiovascular Disorders
    22. Drugs Used to Treat Dyslipidemias
    23. Drugs Used to Treat Hypertension
    24. Drugs Used to Treat Arrhythmias
    25. Drugs Used to Treat Angina Pectoris
    26. Drugs Used to Treat Peripheral Vascular Disease
    27. Drugs Used to Treat Thromboembolic Disorders
    28. Drugs Used to Treat Heart Failure

    UNIT VI: Drugs Affecting the Respiratory System
    29. Drugs Used to Treat Upper Respiratory Disease
    30. Drugs Used to Treat Lower Respiratory Disease

    UNIT VII: Drugs Affecting the Digestive System
    31. Drugs Used to Treat Gastroesophageal Reflux and Peptic Ulcer Disease
    32. Drugs Used to Treat Nausea and Vomiting
    33. Drugs Used to Treat Constipation and Diarrhea

    UNIT VIII: Drugs Affecting the Endocrine System
    34. Drugs Used to Treat Diabetes Mellitus
    35. Drugs Used to Treat Thyroid Disease

    UNIT IX: Drugs Affecting the Reproductive System
    36. Drugs Used in Obstetrics
    37. Drugs Used in Men’s and Women’s Health

    UNIT X: Drugs Affecting Other Body Systems
    38. Drugs Used to Treat Urinary System Disorders
    39. Drugs Used to Treat Glaucoma and Other Eye Disorders
    40. Drugs Used to Treat Cancer
    41. Drugs Used to Treat Musculoskeletal Disorders
    42. Drugs Used to Treat Immune and Inflammatory Disorders

    UNIT XI: Drugs Used to Treat Infections
    43. Drugs Used to Treat Bacterial Infections
    44. Drugs Used to Treat Viral Infections
    45. Drugs Used to Treat Fungal Infections
  • Michelle J. Willihnganz, MS, RN, CNE, RCTC Nursing Instructor, Rochester Community and Technical College, Rochester, Minnesota and Samuel L. Gurevitz, PharmD, CGP, Professor Emeritus, College of Pharmacy and Health Sciences, Butler University, Indianapolis, Indiana
    • Ways of Reading
      • The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
      • This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
      • All content can be read as read aloud speech or dynamic braille
      • Has alternative text descriptions for images
    • Conformance
    • Navigation
      • Table of contents to all chapters of the text via links
      • Index with links to referenced entries
      • Elements such as headings, tables, etc. for structured navigation
      • Page list to go to pages from the print source version
    • Rich Content
      • Math formulas in accessible format (MathML)
      • Information-rich images are described by extended descriptions
    • Hazards
      • The publication contains no hazards
    • Product Content
      • Content includes any type of illustrations.
      • The primary content is text.
      • Content includes maps and/or other cartographic content.
      • Content includes a significant number of actionable (clickable) web links to external content, downloadable resources, supplementary material, etc.
      • Content includes a significant number of actionable (clickable) cross-references, hyperlinked notes and annotations, or with other actionable links between largely textual elements (e.g., quiz/test questions, 'choose your own ending', etc.).
      • Content includes photographs, whether in a plate section / insert or not.
      • Content includes figures, diagrams, charts and/or graphs, including other 'mechanical' (i.e. non-photographic) illustrations.
      • Content includes images displayed in a specific order for the purpose of graphic storytelling or giving information (e.g. graphic novels, comics and manga). May include text integrated into the image (as speech and thought bubbles, textual 'sound' effects, captions etc.).
      • Content includes text within images, including text-as-text embedded in diagrams, charts, or within images containing speech balloons, thought bubbles, captions, etc.
      • Content includes visual content that is purely decorative and is not necessary to understanding of the content.
      • Content includes mathematical notations, formulae.
      • At least some text - including text within other images - is 'text as an image' (i.e., a picture of text).
    • Legal Considerations
      • No information is available
    • Additional Accessibility Information
      • Content is enhanced with ARIA roles to optimize organization and facilitate navigation
      • Page breaks included from the original print source
      • For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
      • The body text is presented with a contrast ratio of at least 4.5:1 (or 3:1 for large/heading text)
      • Ultra-high contrast between text and background
      • E-publication includes basic navigation (usually less detailed than TOC-based navigation)
      • Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
      • All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
      • Content provides explanations for unusual words, abbreviations, acronyms, idioms, jargon in an accessible form, such as glossaries, scripted pop-ups.
      • Where interactive content is included in the product, controls are provided (e.g., for speed, pause and resume, reset) and labelled to make their use clear.
      • The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
Most review copies are eBooks – how fast!
A review copy request is most likely to be fulfilled as an eBook on VitalSource rather than a print product, unless no eBook is available. eBooks become available in as little as a few hours. Print products will take between 7 and 10 days to arrive. To request a print copy, please contact us through the Evolve Support Center for further assistance or contact your Elsevier Sales Rep.
An Access Code
Important note
You are viewing the faculty version.
Students requesting access will be reported.
Student access
Technical Support
Contact your Elsevier Sales Rep to learn more about adopting this product